These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

954 related items for PubMed ID: 9020939

  • 1. [Treatment of malignant melanoma: recent advances and perspectives].
    Saida T.
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):10-5. PubMed ID: 9020939
    [Abstract] [Full Text] [Related]

  • 2. [Chemotherapy of malignant melanoma].
    Ishihara K, Yamazaki N, Asano K.
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
    [Abstract] [Full Text] [Related]

  • 3. [Chemotherapy of malignant melanoma].
    Ishihara K.
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
    [Abstract] [Full Text] [Related]

  • 4. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
    Serrone L, Zeuli M, Sega FM, Cognetti F.
    J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
    [Abstract] [Full Text] [Related]

  • 5. [Diagnosis and treatment of malignant melanoma].
    Ishihara K, Ikegawa S.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1727-34. PubMed ID: 2412493
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of metastasized malignant melanoma].
    Kamanabrou D.
    Praxis (Bern 1994); 2001 Mar 08; 90(10):391-6. PubMed ID: 11305184
    [Abstract] [Full Text] [Related]

  • 7. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy.
    Legha SS.
    Semin Oncol; 1997 Feb 08; 24(1 Suppl 4):S39-43. PubMed ID: 9122733
    [Abstract] [Full Text] [Related]

  • 8. Recombinant interleukin-2-based treatments for advanced melanoma: the experience of the European Organization for Research and Treatment of Cancer Melanoma Cooperative Group.
    Keilholz U, Stoter G, Punt CJ, Scheibenbogen C, Lejeune F, Eggermont AM.
    Cancer J Sci Am; 1997 Dec 08; 3 Suppl 1():S22-8. PubMed ID: 9457389
    [Abstract] [Full Text] [Related]

  • 9. [Melanoma].
    Saida T.
    Gan To Kagaku Ryoho; 2006 Oct 08; 33(10):1386-91. PubMed ID: 17033225
    [Abstract] [Full Text] [Related]

  • 10. Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
    Legha SS, Ring S, Eton O, Bedikian A, Plager C, Papadopoulos N.
    Cancer J Sci Am; 1997 Dec 08; 3 Suppl 1():S9-15. PubMed ID: 9457387
    [Abstract] [Full Text] [Related]

  • 11. [Long-term results of adjuvant chemotherapy after therapeutic lymph node dissection in patients with cutaneous malignant melanoma].
    Kretschmer L, Helmbold P, Emmert S, Marsch WC.
    Hautarzt; 2002 Aug 08; 53(8):536-41. PubMed ID: 12221468
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
    Garbe C.
    Melanoma Res; 1993 Aug 08; 3(4):291-9. PubMed ID: 7693093
    [Abstract] [Full Text] [Related]

  • 13. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
    Buzaid AC, Legha SS.
    Semin Oncol; 1994 Dec 08; 21(6 Suppl 14):23-8. PubMed ID: 7992096
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
    Daponte A, Ascierto PA, Gravina A, Melucci MT, Palmieri G, Comella P, Cellerino R, DeLena M, Marini G, Comella G, Italian Cooperative Oncology Group.
    Cancer; 2000 Dec 15; 89(12):2630-6. PubMed ID: 11135225
    [Abstract] [Full Text] [Related]

  • 15. Rationale for intergroup trial E-3695 comparing concurrent biochemotherapy with cisplatin, vinblastine, and DTIC alone in patients with metastatic melanoma.
    Flaherty LE.
    Cancer J Sci Am; 2000 Feb 15; 6 Suppl 1():S15-20. PubMed ID: 10685653
    [Abstract] [Full Text] [Related]

  • 16. The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
    McClay EF, McClay ME, Monroe L, Baron PL, Cole DJ, O'Brien PH, Metcalf JS, Maize JC.
    Br J Cancer; 2000 Jul 15; 83(1):16-21. PubMed ID: 10883662
    [Abstract] [Full Text] [Related]

  • 17. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA, Gold PJ, Fefer A.
    Semin Oncol; 1997 Feb 15; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [Abstract] [Full Text] [Related]

  • 18. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
    Middleton MR, Lorigan P, Owen J, Ashcroft L, Lee SM, Harper P, Thatcher N.
    Br J Cancer; 2000 Mar 15; 82(6):1158-62. PubMed ID: 10735499
    [Abstract] [Full Text] [Related]

  • 19. [The present status of the multidisciplinary treatment of malignant melanoma].
    Ishihara K, Hayasaka K, Ikegawa S, Kageshita T.
    Gan No Rinsho; 1985 Jul 15; 31(9 Suppl):1073-8. PubMed ID: 4057571
    [Abstract] [Full Text] [Related]

  • 20. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit?
    Hofmann MA, Sterry W, Trefzer U.
    Jpn J Clin Oncol; 2007 Mar 15; 37(3):224-9. PubMed ID: 17472972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.